Clinical trials: Indeterminate Pulmonary Nodules, active
Pulmonary Nodules, Lung Neoplasms
Longitudinal AI-Assisted Management of Indeterminate Pulmonary Nodules
Patients with indeterminate lung nodules often face a choice between continued CT surveillance and invasive investigation. This trial compares management with or without access to an AI report that matches nodules across real…
- Trial name
- NCT07895277
- Testing
- AI-Assisted Longitudinal CT Assessment and Pulmonary Nodule Management
- Where
- China
- Volunteers
- 6,000 people
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Pulmonary Disease
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
DECAMP 1 PLUS aims to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules (8-25 mm).
- Trial name
- NCT04165564
- Testing
- Institutional standard of care, Biosamples of airway and blood
- Where
- 19 sites in United States
- Volunteers
- 85 people
- Sponsor
- Boston University
Indeterminate Pulmonary Nodule
Nodify Lung Testing for Pulmonary Nodules
The STRATIFY Study is an observational study for adults age 40 or older who have a lung nodule that is not clearly benign or cancerous. The study will enroll up to 1,000 participants at about 10-12 U.S.
- Trial name
- STRATIFY (NCT07858552)
- Volunteers
- 1,000 people
- Sponsor
- Biodesix, Inc.
Lung Neoplasm
Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules
This clinical trial studies whether a biomarker platform, the Virtual Nodule Clinic, can be used for the management of lung (pulmonary) nodules that are not clearly non-cancerous (benign) or clearly cancerous (malignant)…
- Trial name
- NCT06638398
- Testing
- Computed Tomography, Diagnostic Procedure, Best Practice
- Where
- 5 sites in United States
- Volunteers
- 400 people
- Sponsor
- Vanderbilt-Ingram Cancer Center
Pulmonary Nodule
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.
- Trial name
- NCT06074133
- Testing
- Blood collection, Chest Computed Tomography
- Where
- 4 sites in United States
- Volunteers
- 103 people
- Sponsor
- Vanderbilt-Ingram Cancer Center
Lung Cancer
Lung Nodule Detection Using Ultra-long FOV PET/CT
Indeterminate lung nodules (6-15mm) are frequent findings in patients undergoing chest CT scanning, but adequate follow-up imaging is currently not in place to facilitate early detection, diagnosis and decision making regarding…
- Trial name
- NCT05463913
- Testing
- 18F-FDG, PET/CT imaging
- Where
- Netherlands
- Volunteers
- 20 people
- Sponsor
- University Medical Center Groningen
Lung Abscess
Biomarkers for Diagnosis of Lung Nodules
A need exists for non-invasive testing to aid in clinical decision-making for Computerized Tomography (CT) scan detected lung nodules of indeterminate etiology.
- Trial name
- Nodule (NCT01085864)
- Where
- United States
- Volunteers
- 550 people
- Sponsor
- University of Colorado, Denver